jubilant life sciences (Emkay) Pain persists, recovery still few quarters away

Disappointment continues in Services business and margins pressure in Product business; Long term gain with short term pain
Date Rating Target Price Recommendation Price Broker house
11 May 2011 hold (from accumulate) 144 159 Emkay Report

No comments:

Post a Comment